Goldman Sachs’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
390,768
+93,331
+31% +$229K ﹤0.01% 4771
2025
Q4
$580K Buy
297,437
+179,721
+153% +$295K ﹤0.01% 5501
2025
Q3
$99.5K Sell
117,716
-197,222
-63% -$145K ﹤0.01% 6078
2025
Q2
$228K Buy
314,938
+143,151
+83% +$108K ﹤0.01% 5595
2025
Q1
$148K Sell
171,787
-23,908
-12% -$35.5K ﹤0.01% 5706
2024
Q4
$329K Buy
195,695
+33,367
+21% +$79.8K ﹤0.01% 5460
2024
Q3
$463K Buy
162,328
+79,439
+96% +$206K ﹤0.01% 5091
2024
Q2
$194K Buy
82,889
+19,853
+31% +$51.8K ﹤0.01% 5278
2024
Q1
$185K Sell
63,036
-3,985
-6% -$11.3K ﹤0.01% 5133
2023
Q4
$200K Sell
67,021
-13,665
-17% -$39.1K ﹤0.01% 5153
2023
Q3
$255K Sell
80,686
-14,475
-15% -$47.1K ﹤0.01% 4960
2023
Q2
$368K Buy
95,161
+3,396
+4% +$9.78K ﹤0.01% 4903
2023
Q1
$254K Buy
91,765
+20,950
+30% +$43.9K ﹤0.01% 5191
2022
Q4
$127K Sell
70,815
-3,752
-5% -$7.24K ﹤0.01% 5423
2022
Q3
$158K Sell
74,567
-3,236
-4% -$8.14K ﹤0.01% 5559
2022
Q2
$209K Sell
77,803
-15,761
-17% -$58.7K ﹤0.01% 5619
2022
Q1
$406K Buy
93,564
+35,888
+62% +$147K ﹤0.01% 5467
2021
Q4
$299K Buy
57,676
+47,253
+453% +$253K ﹤0.01% 5671
2021
Q3
$64K Buy
+10,423
New +$83.1K ﹤0.01% 5996
2021
Q1
Sell
-122,500
Closed -$1.33M 6251
2020
Q4
$1.33M Buy
+122,500
New +$1.29M ﹤0.01% 4014

Other funds holding NAUT